Literature DB >> 19819066

PI 3-kinase/Akt and STAT3 are required for the prevention of TGF-beta-induced Hep3B cell apoptosis by autocrine motility factor/phosphoglucose isomerase.

Wen-Ling Shih1, Ming-Huei Liao, Ping-Yuan Lin, Chi-I Chang, Hsueh-Ling Cheng, Feng-Ling Yu, Jeng-Woei Lee.   

Abstract

We established Hep3B cells stably-expressing wild-type and mutated AMF/PGI with differing enzymatic activities in order to investigate how AMF/PGI affects TGF-beta-induced apoptosis, and demonstrated that AMF/PGI against TGF-beta-induced apoptosis was correlated with its enzymatic activity. AMF/PGI did not alter TGF-beta-receptor expression nor affect TGF-beta-induced PAI-1 gene promoter or Smad3/4 activity. AMF/PGI induced PI 3-kinase activity, IRS and Akt phosphorylation, which can further regulate BAD phosphorylation. Constitutively-active p110 enhanced AMF/PGI-mediated anti-apoptosis activity, and dominant negative Akt alleviated anti-TGF-beta-induced apoptosis. We also demonstrated that STAT3 is a weak anti-apoptotic agent but has an increased anti-apoptotic effect in cooperation with PI 3-kinase/Akt. 2009. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19819066     DOI: 10.1016/j.canlet.2009.09.014

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  Blockade of Notch signaling promotes acetaminophen-induced liver injury.

Authors:  Longfeng Jiang; Michael Ke; Shi Yue; Wen Xiao; Youde Yan; Xiaozhao Deng; Qi-Long Ying; Jun Li; Bibo Ke
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

2.  HIV-1 inhibits autophagy in bystander macrophage/monocytic cells through Src-Akt and STAT3.

Authors:  Jennifer Van Grol; Cecilia Subauste; Rosa M Andrade; Koh Fujinaga; Julie Nelson; Carlos S Subauste
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

3.  Inhibition of Epidermal Growth Factor Receptor and PI3K/Akt Signaling Suppresses Cell Proliferation and Survival through Regulation of Stat3 Activation in Human Cutaneous Squamous Cell Carcinoma.

Authors:  Toshinori Bito; Nahoko Sumita; Masashi Ashida; Arief Budiyanto; Masato Ueda; Masamitsu Ichihashi; Yoshiki Tokura; Chikako Nishigori
Journal:  J Skin Cancer       Date:  2010-12-08

4.  RhoA/ROCK1 regulates Avian Reovirus S1133-induced switch from autophagy to apoptosis.

Authors:  Ping-Yuan Lin; Ching-Dong Chang; Yo-Chia Chen; Wen-Ling Shih
Journal:  BMC Vet Res       Date:  2015-05-06       Impact factor: 2.741

5.  Autocrine motility factor receptor promotes the proliferation of human acute monocytic leukemia THP-1 cells.

Authors:  Yingchao Wang; Lina Ma; Chunmei Wang; Guangyao Sheng; Lei Feng; Chuyun Yin
Journal:  Int J Mol Med       Date:  2015-06-30       Impact factor: 4.101

6.  Evodiamine Induces Apoptosis and Inhibits Migration of HCT-116 Human Colorectal Cancer Cells.

Authors:  Lv-Cui Zhao; Jing Li; Ke Liao; Nian Luo; Qing-Qiang Shi; Zi-Qiang Feng; Di-Long Chen
Journal:  Int J Mol Sci       Date:  2015-11-16       Impact factor: 5.923

7.  AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma.

Authors:  Yiran Li; Yuanhui Jia; Qi Che; Qian Zhou; Kai Wang; Xiao-Ping Wan
Journal:  Oncotarget       Date:  2015-09-22

8.  Neuroleukin/Autocrine Motility Factor Receptor Pathway Promotes Proliferation of Articular Chondrocytes through Activation of AKT and Smad2/3.

Authors:  Kang Tian; Weiliang Zhong; Xifu Zheng; Jinrui Zhang; Pixu Liu; Weiguo Zhang; Han Liu
Journal:  Sci Rep       Date:  2015-10-13       Impact factor: 4.379

9.  Microfluidics‑based optimization of neuroleukin‑mediated regulation of articular chondrocyte proliferation.

Authors:  Kang Tian; Weiliang Zhong; Yingqiu Zhang; Baosheng Yin; Weiguo Zhang; Han Liu
Journal:  Mol Med Rep       Date:  2015-11-10       Impact factor: 2.952

10.  Autocrine motility factor promotes endometrial cancer progression by targeting GPER-1.

Authors:  Yiran Li; Yuanhui Jia; Yiding Bian; Huan Tong; Junjie Qu; Kai Wang; Xiao-Ping Wan
Journal:  Cell Commun Signal       Date:  2019-03-05       Impact factor: 5.712

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.